However, analysis of tumor and matched normal tissues from TCGA database demonstrated that while elevated KLF5 expression was observed in gastrointestinal tumors, its expression was conversely lower in several other cancers, including breast cancer, prostate cancer, and kidney cancer. This evidence concerns the gene KLF5 and kidney cancer.